Department of Respiratory Medicine, Heraklion University Hospital, University of Crete School of Medicine, Heraklion, Crete, Greece.
Semin Respir Crit Care Med. 2020 Apr;41(2):177-183. doi: 10.1055/s-0040-1708058. Epub 2020 Apr 12.
Combined pulmonary fibrosis and emphysema (CPFE) is a clinical entity characterized by the combination of upper lobe emphysema and lower lobe fibrosis, the latter owing to various interstitial lung diseases. These patients have a characteristic lung function profile, with relatively preserved dynamic and static lung volumes, contrasting with a significant reduction of carbon monoxide transfer. The pathogenic mechanisms leading to the coexistence of emphysema with fibrosis remain unclear and different theories have been proposed. CPFE is frequently complicated by pulmonary hypertension, acute exacerbations, and lung cancer leading to poor natural history and prognosis. The syndrome of CPFE represents a distinct pulmonary manifestation in the spectrum of lung diseases associated with connective tissue diseases. Currently, there are no established recommendations regarding the management of patients with CPFE. We provide a review on the existing knowledge of CPFE regarding the epidemiology, pathogenesis, clinical manifestations, radiologic appearance, complications, prognosis, and possible treatment options.
合并性肺纤维化和肺气肿(CPFE)是一种临床实体,其特征是上叶肺气肿和下叶纤维化的结合,后者归因于各种间质性肺疾病。这些患者具有特征性的肺功能谱,动态和静态肺容量相对保留,与一氧化碳转移的显著减少形成对比。导致肺气肿与纤维化共存的发病机制尚不清楚,并提出了不同的理论。CPFE 常伴有肺动脉高压、急性加重和肺癌,导致自然病史和预后不佳。CPFE 综合征代表了与结缔组织疾病相关的肺部疾病谱中的一种独特的肺部表现。目前,CPFE 患者的管理尚无既定建议。我们就 CPFE 的流行病学、发病机制、临床表现、影像学表现、并发症、预后以及可能的治疗选择方面的现有知识进行了综述。